The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
Open accessAbstract
Glutamine is an essential nutrient that regulates energy production, redox homeostasis, and signaling in cancer cells. Despite the importance of glutamine in mitochondrial metabolism, the mitochondrial glutamine transporter has long been unknown. Here, we show that the SLC1A5 variant plays a critical role in cancer metabolic reprogramming by transporting glutamine into mitochondria. The SLC1A5 variant has an N-terminal targeting signal for mitochondrial localization. Hypoxia-induced gene expression of the SLC1A5 variant is mediated by HIF-2α. Overexpression of the SLC1A5 variant mediates glutamine-induced ATP production and glutathione synthesis and confers gemcitabine resistance to pancreatic cancer cells. SLC1A5 variant knockdown and overexpression alter cancer cell and tumor growth, supporting an oncogenic role. This work demonstrates that the SLC1A5 variant is a mitochondrial glutamine transporter for cancer metabolic reprogramming.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For mitochondrial glutaminolysis, cytosolic glutamine must be transported through the inner mitochondrial membrane via the SLC1A5 variant, a mitochondrial glutamine transporter16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“the mitochondrial glutamine transporter, encoded by a transcript variant of the SLC1A5 gene, which encodes a well-known plasma membrane glutamine transporter, was only recently discovered16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Although glutamate is the major downstream product of glutamine, glutamate supplementation during glutamine deprivation cannot rescue the impaired cell growth or mitochondrial respiration16,43–45, indicating that mitochondrial GLS-catalyzed cleavage of the gamma-nitrogen of glutamine is essential for glutaminolysis.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Hypoxic conditions promote the uptake of glutamine by increasing the levels of glutamine transporters such as SLC1A5, the SLC1A5 variant, and SLC38A216,65”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“and the mitochondrial glutamine transporter is strongly associated with glutaminolysis-induced NADPH generation16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Furthermore, redox modulation augmented by increased glutathione synthesis from glutamine was reported to be the mechanism of resistance to gemcitabine in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Impairing glutamine metabolism also induces sensitivity in gemcitabine-resistant pancreatic cancer cells16,84,85.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Indeed, experiments using uniformly labeled 13C-glutamine showed that glutathione was enriched with five 13C atoms in glutathione, suggesting that glutamine is the major source of glutathione16,57,60.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Recently, hypoxia-induced expression of the SLC1A5 variant was shown to be mediated by HIF-2α and to lead to metabolic reprogramming toward glutamine metabolism in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Intriguingly, this study regarding elevated glutamine metabolism in cancer cells also showed that glutaminolysis could in turn reinforce metabolic reprogramming, thus implying that glutamine metabolism plays a crucial role in tumorigenesis and tumor progression16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Additionally, the level of the mitochondrial glutamine transporter controls the cellular ATP level stimulated by glutamine, suggesting that glutamine is an important energy source via mitochondrial glutaminolysis16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“in addition, the expression of the SLC1A5 variant affected the levels of metabolites derived from glucose metabolism, including lactate and ribulose-5-phosphate, the intermediate metabolites in the PPP16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Recently, glutamine was shown to be a major fuel for mitochondrial oxygen consumption in pancreatic cancer cells”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Thus, as the SLC1A5 variant is the only currently known glutamine transporter in the mitochondrial inner membrane16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Given the clinicopathological significance of SLC1A5201 and the observation that the level of the SLC1A5 variant is negatively correlated with prognosis in several cancer types16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Conversely, suppression of the SLC1A5 variant, a mitochondrial glutamine transporter, is sufficient to inhibit tumor growth by impairing glutamine metabolism in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“HIF‐2α‐induced expression of the glutamine transporter solute carrier family 1, member 5 (SLC1A5) mediates glutamine‐induced ATP production and glutathione synthesis and renders pancreatic cancer resistant to gemcitabine.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [56]
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Importing Mitochondrial Proteins: Machineries and Mechanisms
Chacińska, A., Koehler, C. M., Milenkovic, D., Lithgow, T. J., & Pfanner, N. (2009) · Cell · doi:10.1016/j.cell.2009.08.005 · Cited by 1,528
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 447
Jiang, W., Jiang, Y., Zhang, X., Mu, H., Song, Y., & Zhao, H. (2023) · BMC Genomics · doi:10.1186/s12864-023-09361-x · Cited by 5
Current Drugs and their Therapeutic Targets for Hypoxia-inducible Factors in Cancer
Joshi, E., Pandya, M. D., & Desai, U. (2023) · Current Protein and Peptide Science · doi:10.2174/1389203724666230601092245 · Cited by 5
Wang, M., Chen, X., Xu, N.-Y., Li, J., Tang, R., & Liu, X. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.3c01049 · Cited by 4
Rewiring amino acids in cancer
Zhang, Y., Lyu, J., & Fang, H. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189465 · Cited by 4
Voor, S. F., Cooper, A. J. L., & Pinto, J. T. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115989 · Cited by 4
Wang, B., Han, X., Lin, X., Wang, J., You, C., Chen, K., Chen, Y., Meng, F., Jiang, H., Zheng, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64734-y · Cited by 4
Pires, I. S., Billingsley, M. M., Gordon, E., Pickering, A. J., Cai, E., Esparza, G. J., Pryor, M. L., Stoneman, A. D., Kindopp, A., Irvine, D. J., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202519203 · Cited by 4
Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer
Guo, S., & Addison, C. (2026) · Current Oncology · doi:10.3390/curroncol33020129 · Cited by 4
Tang, S., Liu, Q. S., Song, M., Li, X., Ji, D., Yang, Y., & Yu, H. (2024) · APL Materials · doi:10.1063/5.0210252 · Cited by 4
Targeting EPAS-1/HIF-2α Pathway to Address Endocrine Resistance in Luminal A Type Breast Cancer
Luo, E., Lee, S., agarwal, N. M., & Choi, J. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102415 · Cited by 4
Self-citationSłotwiński, R., Lech, G., & Słotwińska, S. M. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2021.107027 · Cited by 4
Characterization and function of mandarin fish c-Myc during viral infection process
Ye, C., Li, N., Niu, Y., Lin, Q., Luo, X., Liang, H., Liu, L., & Fu, X. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.12.045 · Cited by 4
Hu, P., Xu, L., Liu, Y., Zhang, X., Li, Z., Li, Y., & Qiu, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1187108 · Cited by 5
Onyango, C., Anyona, S. B., Hurwitz, I., Raballah, E., Wasena, S. A., Osata, S. W., Seidenberg, P., McMahon, B. H., Lambert, C. G., Schneider, K. A., et al. (2024) · Pathogens · doi:10.3390/pathogens13100867 · Cited by 3
Luo, E., Agarwal, N. M., & Choi, J. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00170 · Cited by 3
Self-citationEffects of SLC6A8 mutation-induced creatine deficiency on cellular function in fibroblasts
Ito, S., Uemura, T., Miyano, A., Shimbo, H., Masuda, T., Goto, T., Osaka, H., Wada, T., & Ohtsuki, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-11386-z · Cited by 3
Yang, Y., Xu, J., Zhao, Q., Zhang, R., Wang, Y., Shang, C., Pan, S., Hu, C., & Luo, C. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147333 · Cited by 3
Ying, H., Wang, Y., Zhu, D., Xu, J., Zhang, X., Pan, H., Zeng, Y., Wu, X., Cai, W., Zhou, R., et al. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01586-6 · Cited by 3
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Lin, C., Hadfield, M. J., Rathore, A., Pinho-Schwermann, M. P., Zhang, S., Lu, S., den Hollander, P., Mani, S. A., Seyhan, A. A., Santopietro, A., et al. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103061 · Cited by 4
Roles and therapeutic targeting of SLC transporters in gastrointestinal malignancies
Wang, J., Huang, X., Chen, S., Zhang, Y., Miao, G., Du, S., Wang, X., Lu, Y., & Zhao, X. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218222 · Cited by 3
Neurotransmitters: Key regulators of the tumor immune microenvironment
Zhang, L., Jing, W., Li, Y., Ping, Y., & Zhang, Y. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102015 · Cited by 3
Zhang, S. X., chen, Z., Ma, C., Hu, J., Lin, S., Gao, J., & Chen, S. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70334 · Cited by 3
Zhang, Y., Xiao, Z., Southwell, J. W., Gao, R., Saubaméa, B., Moinard, M., Arnoux, P., Frochot, C., Mesdom, P., & Gasser, G. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c04446 · Cited by 3
Cancer Drug Resistance and Metabolic Reprogramming
Jan, S., Fatima, K., Wani, A., Malik, F. A., & Khan, S. U. (2024) · Springer eBooks · doi:10.1007/978-981-97-1666-1_6 · Cited by 3
Wang, S., Ho, Y.-C., Chou, C., Chang, Y., Lee, H., & Tseng, L. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106688 · Cited by 3
Self-citationKhairi, S., Wang, C., Anuraga, G., Prayugo, F. B., Ansar, M., Lesmana, M. H. S., Irham, L. M., Shen, C., & Chung, M. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15040134 · Cited by 3
Lin, J., Yang, X. F., Zhao, K., & Liu, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1585639 · Cited by 3
Dynamic Mechanisms of Neutral Amino Acid Exchanger ASCT2 Transporting Substrate Glutamine
Zhang, H., Zhang, M., Hou, H., Chen, Y., Sun, W., & Wang, Q. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00710 · Cited by 3
Metabolic Reprogramming and Molecular Rewiring in Cancer: Therapeutic Opportunities
Meiliana, A., Dewi, N. M., & Wijaya, A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1598 · Cited by 3
Ohgaki, R., Hirase, Y., Xu, M., Okanishi, H., & Kanai, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-70603-3 · Cited by 3
The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer
Chiu, C., Lin, H.-R., Su, Y., Chen, H., Hung, S., & Huang, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111797 · Cited by 3
Alternative splicing: hallmark and therapeutic opportunity in metabolic liver disease
Jiang, M., Alqahtani, S. A., Seto, W., Yilmaz, Y. N., Pan, Z., Valenti, L. V. C., & Eslam, M. (2025) · Gastroenterology report · doi:10.1093/gastro/goaf044 · Cited by 3
Wohlrab, H., Signoretti, S., Rameh, L. E., DeConti, D. K., & Hansen, S. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-21411-0 · Cited by 4
Glutamine-dependent effects of nitric oxide on cancer cells subjected to hypoxia-reoxygenation
Xing, D., Benavides, G. A., Johnson, M. S., Tian, R., Barnes, S., & Darley-Usmar, V. M. (2022) · Nitric Oxide · doi:10.1016/j.niox.2022.11.003 · Cited by 3
Li, C., Qin, C., Li, X., Wang, J., Li, Y., & Sun, Q. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5845 · Cited by 3
Glutamine transporters as effective targets in digestive system malignant tumor treatment
CHU, F., TONG, K., Gu, X., BAO, M., Chen, Y., Wang, B., SHAO, Y., & Wei, L. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.048287 · Cited by 2
Li, F., Vigder, N., Ziehr, D. R., Kamiya, M., Nguyen, H. N., Faustino, D. E. F., Khalil, A. H., Lam, H. C., Steinhauser, M. L., Kim, E. Y., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.199449 · Cited by 2
Meng, H., Xiao, Z., Wang, Q., Li, D., & Li, Z. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02034-8 · Cited by 2
Yadav, A., Schmitt, S., Ma, W., Mobley, J. A., & Thalacker‐Mercer, A. E. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00568.2025 · Cited by 2
Zhang, Y., Niu, L., Xia, H., & Wang, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1733368 · Cited by 2
Ding, J., Liu, J., Liang, L., Wang, W., Li, Y., Zhu, C., Wen, J., He, Z., Li, J., Zhang, Y., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.70969 · Cited by 2
Yang, P., Gao, Z., Ye, W., Zhou, C., Zheng, Z., Su, M., He, Y., Li, Z., Pelisek, J., He, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71856-4 · Cited by 2
Re-evaluating the rationale for targeting oxidative phosphorylation in acute myeloid leukemia
Chrest, B. R., & Fisher‐Wellman, K. H. (2026) · Biochemical Journal · doi:10.1042/bcj20260185 · Cited by 2
Mitochondria: from powerhouses of cells to hubs in antitumor immunity
Li, X., Shi, Y., Zhao, Y., Zhu, G., & Jin, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1852236 · Cited by 2
Illuminating spatial dynamics of glutamine metabolism with a sensitive genetically encoded biosensor
Scully, J. M., Sun, M. J., Das, S., Arias, N. J., Kapelczak, E. D., Robinson, T. D., Vineall, K. G., Dean, T. S., TeSlaa, T. A., Divakaruni, A. S., et al. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00164e · Cited by 2
Zang, X., Lei, K., Wang, J., Gong, R., Gao, C., Jing, Z., Song, J., & Ren, H. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155071 · Cited by 2
LINC01134 Directly Binds and Regulates SLC1A5 Stability to Promotes Colorectal Cancer Progression
Li, Y., Wu, J., Wang, X., & Wang, N. (2024) · Journal of Cancer · doi:10.7150/jca.100147 · Cited by 2
Lyda, B. R., Leary, G. P., Farnsworth, J. C., Silvius, D., Seaver, B., Esslinger, C. S., Natale, N. R., & Kavanaugh, M. P. (2024) · Molecules · doi:10.3390/molecules29102330 · Cited by 2
Mitochondrial apolipoprotein MIC26 is a metabolic rheostat regulating central cellular fuel pathways
Damiecki, M., Naha, R., Schaumkessel, Y., Westhoff, P., Atanelov, N., Stefanski, A., Petzsch, P., Stühler, K., Köhrer, K., Weber, A. P. M., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202403038 · Cited by 2
Dernie, F. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102422 · Cited by 2
Wang, M., & Chang, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1537547/v1 · Cited by 2
Jose, A. C., Syu, Y.-W., Lai, H.-W., Tsai, M., Jiang, Y.-F., Hsu, S., Lin, P.-Y., Huang, W., Chu, W.-C., Fu, C., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115891 · Cited by 1
Wang, M., Yao, M., Yue, H., Tian, Y., Zhao, Z., Xue, C., Zhang, T., & Wang, Y. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250417 · Cited by 1
Zhang, X., Ren, W., Li, D., Si, Y., Yang, C., Wang, L., & Song, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143127 · Cited by 1
Dou, Y. (2025) · New cell · doi:10.61958/ncjt1177 · Cited by 1
CircRBM33 facilitates colorectal cancer progression by regulating the miR-512–5p/SLC1A5 axis
Zhang, J., Zhang, L., Tanaka, K., Shi, F., She, J., & He, S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156248 · Cited by 1
Qu, W., Tan, W., Ye, M., Tang, W., Zhang, L., & Luo, G. (2025) · Oncology Letters · doi:10.3892/ol.2025.15352 · Cited by 2
He, M., Song, K., Luo, Y., Lai, G., Tan, L., Liu, X., Guo, Y., Jiang, Z., Zou, J., Li, W., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02164-w · Cited by 1
Tawai, J., & Xiong, J. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01756-2 · Cited by 1
Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective
Li, X., Lyu, H., Wu, Y., Chen, A., Wu, G., Zhang, R., Xiao, S., Guo, D., Zhang, Q., Yan, C., et al. (2026) · Biology · doi:10.3390/biology15070574 · Cited by 1
Targeting glutamine metabolism to modulate macrophage functions in the tumor microenvironment
Wu, S., Peng, Y., Wang, Q. J., Li, Z., Ge, K., & Ye, L. (2026) · Discover Oncology · doi:10.1007/s12672-026-04999-x · Cited by 1
Lapatinib induces ferroptosis in osteosarcoma via the SLC1A5-GPX4 axis
Miao, H., Fu, X., Liu, B., Pan, X., Han, Y., & Yu, Z. (2026) · Journal of bone oncology · doi:10.1016/j.jbo.2026.100771 · Cited by 1
Fan, H., Li, X., Song, H., Zhang, S., Tian, Z., Chen, Y., Zhou, J., Geng, S., Liu, H., Wang, Y., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124406 · Cited by 1
RNA methylation, metabolic reprogramming and pulmonary hypertension
Hu, L., Shen, Y., Gan, X., Zhang, Y., Feng, Y., Wang, J., & Chen, F. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0908 · Cited by 1
Du, C., Hu, Y., Yang, X., Zhang, Z., Gu, J., Zhang, T., Wang, R., Zhang, S., Tan, L., & Yu, G. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27047 · Cited by 1
Li, X., He, X., Sun, Y., & Yang, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07303-7 · Cited by 1
Yao, J.-T., Hu, P.-C., Li, X., Xu, J., Wang, K., Ye, S., Meng, X.-Y., Chen, H., Liang, Y., & Ma, Q. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101991 · Cited by 1
A dual-mechanism model of Selinexor in DLBCL: p53 reactivation and metabolic reprogramming
Zhang, W., Shi, L., Li, Y., He, C., Cui, S., Liu, Y., Wang, X., Liu, L., Gao, Y., Diao, L., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08014-3 · Cited by 1
Kaarunya, S., Sinduja, P., Yuwanati, M. B., & Mullainathan, S. M. (2026) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2026.101448 · Cited by 1
Genipin induces liver injury by disrupting the CPS1-regulated urea cycle and redox homeostasis
Xu, H., Huang, X., Zhang, Y., Gong, S., Luo, Y., Fang, Y., Hu, X., Luo, M., Zhai, Y., Gao, F., et al. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101647 · Cited by 1
Liu, Y., Xiong, H., Yan, C., Wang, Y., Cao, W., & Qie, S. (2023) · PubMed Central · doi:10.22074/cellj.2023.2004011.1319 · Cited by 1
Zhu, M., XU, T., Zhang, H., FAN, X., WANG, Y., ZHANG, J., & YU, F. (2023) · Biocell · doi:10.32604/biocell.2023.028968 · Cited by 1
Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer
Schwarzenbach, H. (2024) · Non-Coding RNA · doi:10.3390/ncrna10050051 · Cited by 2
Neumann, E., Sohn, Y. S., Karmi, O., Darash‐Yahana, M., Cárdenas, A. E., Pikarsky, E., Elber, R., Friedler, A., Onuchic, J. N., Mittler, R., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119611 · Cited by 1
Heterologous Expression of Human SLC1A5v2 as a Functional Glutamine Transporter in Escherichia coli
Kim, E., Park, J. W., & Kim, O. B. (2023) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2301.01011 · Cited by 1
Peng, M., Mathew, N. D., Anderson, V. E., Falk, M. J., & Nakamaru‐Ogiso, E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.09.602756 · Cited by 1
Survival-associated Metabolic Genes in Colon and Rectal CancersPreprint
Cui, Y., Han, B., Zhang, H., Wang, Z., Liu, H., Zhang, F., & Niu, R. (2020) · Research Square · doi:10.21203/rs.3.rs-117478/v1
Mitochondria and cancer therapy
Handali, S., Rezaei, M., & Pourahmad, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00010-5
Xu, Z. D., Cai, X., & Ye, J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4176716
Identification of critical mitochondrial hub gene for facial nerve regeneration
Cao, X., Zhang, Y., Shi, Y., Li, Y., Gao, L., Wang, X., & Sun, L. D. (2023) · Biochemistry and Cell Biology · doi:10.1139/bcb-2023-0224
Eldehna, W. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15635-9.00013-4
LncRNA: Secret Regulators of Cancer Metabolism
Demirkaya, D. B., & Yalçın, S. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_470
Liu, B., Zhao, Z., Wang, P., Aihemaiti, K., Zhu, L., Wei, Q., Li, W., Yuan, X., Wu, J., Jiang, C., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202416608
Metabolic Supremacy Fuels Tumor Aggressiveness in Renal Cancer
Gholam, R., & Khalilzad, M. (2025) · annals of urologic oncology · doi:10.32948/auo.2025.03.01
Zhang, H., Wang, S., Wu, P., Hu, Z., Chen, Y., Guan, Y., & Pang, J. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.02.007
Chen, S.-Q., Zhang, S., Liu, P., Wu, Y., Li, S., Ma, J., Li, W.-J., Lu, S., & Wang, J. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101457
Lei, M., Xu, J., Hu, X., Feng, L., & Luo, B. (2025) · Biocell · doi:10.32604/biocell.2025.068926
Optoacoustic imaging of the brain in a cachexia-inducing pancreatic cancer xenograft
Yousf, S., Penet, M., Brannen, A. D., Winnard, P., Mironchik, Y., Krishnamachary, B., & Bhujwalla, Z. M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1580640
Maurer, J., Mukherjee, P., Ta, N. L., Lee, D. C., Duraj, T., Henao, J., Kiebish, M., Cura, D. V., Herdocia, M., & Seyfried, T. N. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2025-0238
MRI of ASCT2-mediated amino acid uptake in xenograft tumor modelsPreprint
Ghaemi, B., Krishnamachary, B., Dillman, N., Williams, K. N. B., Hodo, Y., Li, Y., Penet, M., Pomper, M. G., Tressler, C. M., Bhujwalla, Z. M., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7367339/v1
Pan, T., Yuan, L., Zhao, R., Lu, L., Zhi, Y., Li, Y., Wu, M., & Huang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70044
Lyu, Z., Zhang, X., Yuan, H., Yang, Q., Yu, Y., Zhao, Z., Wang, G., & Bi, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694137
Wu, G., Zhu, L., Xue, F., & Zhao, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03925-x
Chen, J., Ding, C., Huang, H., Zhao, Z., Zhao, W., Li, X., Zhang, H., Liu, M., Chen, C., Li, Y., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7937446/v1
Amino acid transport through cell membranes
Holeček, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-44534-7.00015-6
Cui, D., Li, M., Fu, R., Sun, Z., Li, Z., Guo, W., & Fei, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2744966/v1
Cai, Y., Dong, Z., & Wang, J. (2022) · Figshare · doi:10.6084/m9.figshare.21269489
Jiang, W., Jiang, Y., Zhang, X., Mu, H., Song, Y., & Zhao, H. (2023) · Figshare · doi:10.6084/m9.figshare.22978267
Chang, Z. W., Fu, Y., Jia, Y., Gao, M., Song, L., Zhang, W., Zhao, R., & Qin, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16633172
Metadata
- Authors
- Yoo, H. C., Park, S. J., Nam, M., Kang, J., Kim, K., Yeo, J. H., Kim, J.-K., Heo, Y., Lee, H. S., Lee, M. Y., Lee, C. W., Kang, J. S., Kim, Y.-H., Lee, J., Choi, J., Hwang, G.-S., Bang, S., & Han, J. M.
- Affiliations
- Yonsei University (KR)
- Korea Basic Science Institute (KR)
- National Cancer Center (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Han, Jung Min
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 267-283.e12
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2995576736
- Cited by
- 449
- References
- 54
- Citations by year
- 2026: 65 · 2025: 78 · 2024: 87 · 2023: 67 · 2022: 67 · 2021: 55 · 2020: 29
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Research Foundation of Korea
- Korea Basic Science Institute
- Ministry of Education (2018R1A6A1A03023718)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glutamine transport, tumor metabolic reprogramming, mitochondrial targeting signal, HIF-2α, hypoxia, glutathione synthesis, ATP production, gemcitabine resistance, pancreatic cancer, tumor growth
- MeSH terms
- Tumor Hypoxia, Endothelial PAS Domain-Containing Protein 1, Animals, Female, Glutamine, Humans, Mice, Inbred BALB C, Mitochondria, Neoplasms, Minor Histocompatibility Antigens, Amino Acid Transport System ASC, Cell Line, Tumor, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
